Endogenous and Exogenous Hydrogen Sulfide Promotes Resolution of Colitis in Rats

被引:274
作者
Wallace, John L. [1 ]
Vong, Linda [1 ]
McKnight, Webb [1 ]
Dicay, Michael [1 ]
Martin, Gary R. [1 ]
机构
[1] Univ Calgary, Fac Med, Inflammat Res Network, Calgary, AB, Canada
基金
加拿大健康研究院;
关键词
CYCLOOXYGENASE-2-DERIVED PROSTAGLANDIN D-2; INFLAMMATORY BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; GASTROINTESTINAL SAFETY; HUMAN COLON; IN-VITRO; MODEL; NEUROMODULATOR; INHIBITION;
D O I
10.1053/j.gastro.2009.04.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Hydrogen sulfide (H2S) is an endogenous gaseous mediator of mucosal defense with antiinflammatory effects that promote ulcer healing. The effects of H2S during the pathogenesis of colitis have not been established. We analyzed the contribution of H2S to inflammation and ulceration of the colon in a rat model OF colitis. METHODS: Colitis was induced by intracolonic administration of trinitrobenzene sulfonic acid. The ability of the colon to synthesize H2S Was Studied over the course of the resolution of the colitis. Expression of 2 enzymes involved in the synthesis of H2S and the effects of inhibitors of these enzymes were examined. We also examined the effects of H2S donors on the resolution of colitis. RESULTS: The capacity for the colon to produce H2S increased markedly over the first days after induction of colitis and then declined toward control levels as the colitis was resolved. inhibition of colonic H2S synthesis markedly exacerbated the colitis, resulting in significant mortality. Inhibition of H2S synthesis in healthy rats resulted in inflammation and mucosal injury in the small intestine and colon along with down-regulation of cyclooxygenase-2 messenger RNA expression and prostaglandin synthesis. Intracolonic administration of H2S donors significantly reduced the severity of colitis and reduced colonic expression of messenger RNA for the proinflammatory cytokine tumor necrosis factor a. CONCLUSIONS: In rats, H2S modulates physiological inflammation and contributes to the resolution of colitis.
引用
收藏
页码:569 / 578
页数:10
相关论文
共 48 条
[1]  
Abe K, 1996, J NEUROSCI, V16, P1066
[2]   ACETYLENIC ENZYME INACTIVATORS - INACTIVATION OF GAMMA-CYSTATHIONASE, IN-VITRO AND IN-VIVO, BY PROPARGYLGLYCINE [J].
ABELES, RH ;
WALSH, CT .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1973, 95 (18) :6124-6125
[3]  
Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238
[4]   Evidence that hydrogen sulfide is a genotoxic agent [J].
Attene-Ramos, MS ;
Wagner, ED ;
Plewa, MJ ;
Gaskins, HR .
MOLECULAR CANCER RESEARCH, 2006, 4 (01) :9-14
[5]   Sulfides impair short chain fatty acid β-oxidation at acyl-CoA dehydrogenase level in colonocytes:: Implications for ulcerative colitis [J].
Babidge, W ;
Millard, S ;
Roediger, W .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 181 (1-2) :117-124
[6]   Diallyl trisulfide inhibits tumor necrosis factor-α expression in inflammed mucosa of ulcerative colitis [J].
Bai, AP ;
Qin, OY ;
Hu, RW .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (08) :1426-1431
[7]   Hydrogen sulfide mediates the vasoactivity of garlic [J].
Benavides, Gloria A. ;
Squadrito, Giuseppe L. ;
Mills, Robert W. ;
Patel, Hetal D. ;
Isbell, T. Scott ;
Patel, Rakesh P. ;
Darley-Usmar, Victor M. ;
Doeller, Jeannette E. ;
Kraus, David W. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (46) :17977-17982
[8]   RELATIONSHIP BETWEEN ARACHIDONIC-ACID METABOLISM, MYELOPEROXIDASE ACTIVITY AND LEUKOCYTE INFILTRATION IN A RAT MODEL OF INFLAMMATORY BOWEL-DISEASE [J].
BOUGHTONSMITH, NK ;
WALLACE, JL ;
WHITTLE, BJR .
AGENTS AND ACTIONS, 1988, 25 (1-2) :115-123
[9]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[10]   Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety [J].
Chavez-Pina, A. E. ;
Vong, L. ;
McKnight, W. ;
Dicay, M. ;
Zanardo, R. C. O. ;
Ortiz, M. I. ;
Castaneda-Hernandez, G. ;
Wallace, J. L. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (06) :857-864